Parthiban Brindha Devi

Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease

C. Shivanika, Deepak Kumar S., V. Ragunathan et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 333 citations · Full text

Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors

Ganesh Samala, Parthiban Brindha Devi, Shalini Saxena et al. · Bioorganic & Medicinal Chemistry · 2016 · 65 citations · Full text

Natural Product Synthesis, Bioorganic Chemistry, Medicine +8

Identification of novel inhibitors against Mycobacterium tuberculosis l-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening

Shalini Saxena, Parthiban Brindha Devi, Vijay Soni et al. · Journal of Molecular Graphics and Modelling · 2013 · 39 citations

Pulmonary Tuberculosis, Drug Target, Biochemistry +10

Design and development of novel Mycobacterium tuberculosis l-alanine dehydrogenase inhibitors

Shalini Saxena, Ganesh Samala, Jonnalagadda Padma Sridevi et al. · European Journal of Medicinal Chemistry · 2014 · 35 citations

Pulmonary Tuberculosis, Biochemistry, Medicine +7

Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors

Ganesh Samala, Parthiban Brindha Devi, Radhika Nallangi et al. · European Journal of Medicinal Chemistry · 2013 · 34 citations · Full text

Natural Product Synthesis, Biochemistry, Medicine +5